Focal corneal decompensation after filtering surgery with mitomycin C

Cornea

Volumn 26, Issue 10, 2007, Pages 1285-1287

  Mohammadpour, Mehrdad ^a   Jabbarvand, Mahmood ^a   Javadi, Mohammad Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Corneal decompensation; Filtering surgery; Mitomycin C

Indexed keywords

ANTIGLAUCOMA AGENT; DORZOLAMIDE; MITOMYCIN C; TIMOLOL;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CASE REPORT; CELL DENSITY; CORNEA EDEMA; ENDOTHELIAL DYSFUNCTION; EYE EXAMINATION; EYE LAVAGE; FILTERING OPERATION; FOCAL CORNEAL DECOMPENSATION; HUMAN; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; MALE; PHOTOPHOBIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SLIT LAMP; THORAX RADIOGRAPHY; VISUAL ACUITY;

ADULT; ALKYLATING AGENTS; COMBINED MODALITY THERAPY; CORNEAL EDEMA; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MITOMYCIN; TRABECULECTOMY;

EID: 36549001819     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318150d371     Document Type: Article

References (18)

1. Pievetti-Pezzi P, Accorinti M, La Cava M, et al. Endogenous uveitis: an analysis of 1417 cases. Ophthalmologica. 1996;210:234-238.
2. Monowarul Islam SM, Tabbara KF. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol. 2002;9:239-249.
3. Velilla S, Dios E, Herreras JM, et al. Fuchs' heterochromic iridocyclitis: a review of 26 cases. Ocul Immunol Inflamm. 2001;9:169-175.
4. La Hey E, de Vries J, Langerhorst CT, et al. Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis. Am J Ophthalmol. 1993;116:327-340.
5. Jones NP. Glaucoma in Fuchs' heterochromic uveitis: etiology, management and outcome. Eye. 1991;5:662-667.
6. Joos KM, Lavina AM, Tawansy KA, et al. Posterior repositioning of glaucoma implants for anterior segment complications. Ophthalmology. 2001;108:279-284.
7. Domingo Gordo B, Urcelay Segura JL, Conejero Arroyo J, et al. Corneal descompensation in patients with endothelial compromise treated with topical dorzolamide. Arch Soc Esp Oftalmol. 2002;77:139-144.
8. Konowal A, Morrison JC, Brown SVL, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127:403-406.
9. Zabel RW, MacDonald IM, Mintsioulis G. Corneal endothelial decompensation after argon laser iridotomy. Can J Ophthalmol. 1991;26:367-373.
10. Buffen AN, Saetre SB, Higginbotham EJ, et al. Transconjunctival mitomycin C as an adjunct to conventional glaucoma filtration surgery in rabbits. J Glaucoma. 1997;6:314-318.
11. Mietz H, Roters S, Krieglstein GK. Bullous keratopathy as a complication of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2005;243:1284-1287.
12. Bank A, Allingham RR. Application of mitomycin C during filtering surgery. Am J Ophthalmol. 1993;116:377-379.
13. Shin DH, Reed SY, Swords RC, et al. Cellulose sponge punch for controlled mitomycin application. Arch Ophthalmol. 1994;112:1624-1625.
14. Flynn WJ, Carlson DW, Bifano SL. Mitomycin trabeculectomy: the microsurgical sponge difference. J Glaucoma. 1995;4:86.
15. Prata JA Jr, Minckler DS, Mermoud A, et al. Effects of intraoperative mitomycin-C on the function of Baerveldt glaucoma drainage implants in rabbits. J Glaucoma. 1996;5:29-38.
16. Song JS, Kim JH, Yang M, et al. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application: effects of mitomycin-C application time and concentration. Cornea. 2007;26:461-467.
17. Vass C, Georgopoulos M, Ei M, et al. Intrascleral concentration vs. depth profile of mitomycin-C after episcleral application: impact of irrigation. Exp Eye Res. 2000;70:139-143.
18. Georgopoulos M, Vass C, Vatanparast Z. Impact of irrigation in a new model for in vitro diffusion of mitomycin-C after episcleral application. Curr Eye Res. 2002;25:221-225.